UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place

Frontiers in immunology, 2019-11, Vol.10, p.2760-2760

2019

Volltextzugriff (PDF)

Oral Administration of the Probiotic Strain Escherichia coli Nissle 1917 Reduces Susceptibility to Neuroinflammation and Repairs Experimental Autoimmune Encephalomyelitis-Induced Intestinal Barrier Dysfunction

Frontiers in immunology, 2017-09, Vol.8, p.1096-1096

2017

Volltextzugriff (PDF)

Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy

Journal of hypertension, 2014-11, Vol.32 (11), p.2211-2223

2014

Volltextzugriff (PDF)

Barriers for orally inhaled therapeutic antibodies

Expert opinion on drug delivery, 2023-08, Vol.20 (8), p.1071-1084

2023

Volltextzugriff (PDF)

Escherichia coli producing colibactin triggers premature and transmissible senescence in mammalian cells

PloS one, 2013-10, Vol.8 (10), p.e77157-e77157

2013

Volltextzugriff (PDF)

MAIT Cells Display a Specific Response to Type 1 IFN Underlying the Adjuvant Effect of TLR7/8 Ligands

Frontiers in immunology, 2020-09, Vol.11 (article 2097), p.2097-2097

2020

Volltextzugriff (PDF)

Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease

American journal of physiology. Renal physiology, 2021-08, Vol.321 (2), p.F149-F161

2021

Volltextzugriff (PDF)

In a murine model of acute lung infection, airway administration of a therapeutic antibody confers greater protection than parenteral administration

Journal of controlled release, 2019-06, Vol.303, p.24-33

2019

Volltextzugriff (PDF)

Alternative Routes of Administration for Therapeutic Antibodies—State of the Art

Antibodies (Basel), 2022-08, Vol.11 (3), p.56

2022

Volltextzugriff (PDF)

The proteolytic airway environment associated with pneumonia acts as a barrier for treatment with anti-infective antibodies

European journal of pharmaceutics and biopharmaceutics, 2024-02, Vol.195, p.114163-114163, Article 114163

2024

Volltextzugriff (PDF)

Inhalable Nanofitin demonstrates high neutralization of SARS-CoV-2 virus via direct application in respiratory tract

Molecular therapy, 2023-10, Vol.31 (10), p.2861-2871

2023

Volltextzugriff (PDF)

Therapeutic antibodies – natural and pathological barriers and strategies to overcome them

Pharmacology & therapeutics (Oxford), 2022-05, Vol.233, p.108022-108022, Article 108022

2022

Volltextzugriff (PDF)

Mice as stowaways? Colonization history of Danish striped field mice

Biology letters (2005), 2017-07, Vol.13 (7), p.20170064-20170064

2017

Volltextzugriff (PDF)

Mucosal administration of anti-bacterial antibodies provide long-term cross-protection against Pseudomonas aeruginosa respiratory infection

Mucosal immunology, 2023-06, Vol.16 (3), p.312-325

2023

Volltextzugriff (PDF)

Oral supplementation with yeast β -glucans improves the resolution of Escherichia coli -associated inflammatory responses independently of monocyte/macrophage immune training

Frontiers in immunology, 2022-12, Vol.13, p.1086413-1086413

2022

Volltextzugriff (PDF)

The Food Contaminant Deoxynivalenol Exacerbates the Genotoxicity of Gut Microbiota

mBio, 2017-03, Vol.8 (2)

2017

Volltextzugriff (PDF)

The anti-Pseudomonas aeruginosa antibody Panobacumab is efficacious on acute pneumonia in neutropenic mice and has additive effects with meropenem

PloS one, 2013-09, Vol.8 (9), p.e73396

2013

Volltextzugriff (PDF)

Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal Inflammation

Cell reports (Cambridge), 2016-08, Vol.16 (8), p.2208-2218

2016

Volltextzugriff (PDF)

Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation

PLoS pathogens, 2010-01, Vol.6 (1), p.e1000744-e1000744

2010

Volltextzugriff (PDF)

Glucagon-like peptide-1 receptor agonists increase pancreatic mass by induction of protein synthesis

Diabetes (New York, N.Y.), 2015-03, Vol.64 (3), p.1046-1056

2015

Volltextzugriff (PDF)

Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity

Gut microbes, 2012-11, Vol.3 (6), p.501-509

2012

Volltextzugriff (PDF)

Phylogeography using mitogenomes: A rare Dipodidae, Sicista betulina, in North‐western Europe

Ecology and evolution, 2022-04, Vol.12 (4), p.e8865-n/a

2022

Volltextzugriff (PDF)

The probiotic strain Escherichia coli Nissle 1917 prevents papain-induced respiratory barrier injury and severe allergic inflammation in mice

Scientific reports, 2018-07, Vol.8 (1), p.11245-11, Article 11245

2018

Volltextzugriff (PDF)

DNA Inversion Regulates Outer Membrane Vesicle Production in Bacteroides fragilis

PloS one, 2016-02, Vol.11 (2), p.e0148887-e0148887

2016

Volltextzugriff (PDF)

Therapeutic Antibodies for the Treatment of Respiratory Tract Infections-Current Overview and Perspectives

Vaccines (Basel), 2021-02, Vol.9 (2), p.151

2021

Volltextzugriff (PDF)

1 – 25 von 240

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(230)
Mit Volltextzugriff
(217)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(151)
Life Sciences & Biomedicine
(138)
Humans
(81)
Male
(59)
Animals
(55)
Life Sciences
(47)
Female
(41)
Physiology
(34)
Mice
(33)
Adult
(29)
Biological And Medical Sciences
(29)
Immunology
(26)
Fundamental And Applied Biological Sciences. Psychology
(21)
Diabetes
(18)
Exercise
(18)
Neurosciences & Neurology
(17)
Neurosciences
(16)
Pharmacology & Pharmacy
(16)
Rodents
(16)
Diabetes Mellitus
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place

Oral Administration of the Probiotic Strain Escherichia coli Nissle 1917 Reduces Susceptibility to Neuroinflammation and Repairs Experimental Autoimmune Encephalomyelitis-Induced Intestinal Barrier Dysfunction

Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy

Barriers for orally inhaled therapeutic antibodies

Escherichia coli producing colibactin triggers premature and transmissible senescence in mammalian cells

MAIT Cells Display a Specific Response to Type 1 IFN Underlying the Adjuvant Effect of TLR7/8 Ligands

Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease

In a murine model of acute lung infection, airway administration of a therapeutic antibody confers greater protection than parenteral administration

Alternative Routes of Administration for Therapeutic Antibodies—State of the Art

The proteolytic airway environment associated with pneumonia acts as a barrier for treatment with anti-infective antibodies

Inhalable Nanofitin demonstrates high neutralization of SARS-CoV-2 virus via direct application in respiratory tract

Therapeutic antibodies – natural and pathological barriers and strategies to overcome them

Mice as stowaways? Colonization history of Danish striped field mice

Mucosal administration of anti-bacterial antibodies provide long-term cross-protection against Pseudomonas aeruginosa respiratory infection

Oral supplementation with yeast β -glucans improves the resolution of Escherichia coli -associated inflammatory responses independently of monocyte/macrophage immune training

The Food Contaminant Deoxynivalenol Exacerbates the Genotoxicity of Gut Microbiota

The anti-Pseudomonas aeruginosa antibody Panobacumab is efficacious on acute pneumonia in neutropenic mice and has additive effects with meropenem

Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal Inflammation

Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation

Glucagon-like peptide-1 receptor agonists increase pancreatic mass by induction of protein synthesis

Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity

Phylogeography using mitogenomes: A rare Dipodidae, Sicista betulina, in North‐western Europe

The probiotic strain Escherichia coli Nissle 1917 prevents papain-induced respiratory barrier injury and severe allergic inflammation in mice

DNA Inversion Regulates Outer Membrane Vesicle Production in Bacteroides fragilis

Therapeutic Antibodies for the Treatment of Respiratory Tract Infections-Current Overview and Perspectives

Suchergebnisse filtern